Transcriptional complexes engaged by apo-estrogen receptor-α isoforms have divergent outcomes

EMBO Journal

Volumn 23, Issue 18, 2004, Pages 3653-3666

  Métivier, Raphaël ^a,b   Penot, Graziella ^a,b   Carmouche, Richard P ^a   Hübner, Michael R ^a   Reid, George ^a   Denger, Stefanie ^a   Manu, Dominique ^a   Brand, Heike ^a   Koš, Martin ^a,c   Benes, Vladimir ^a   Gannon, Frank ^a  

^a EUROPEAN MOLECULAR BIOLOGY LABORATORY   (Germany)

^b UNIVERSITÉ DE RENNES 1   (France)

^c UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

ChIP; Estrogen receptor; Methylation; Transcription; Unliganded

Indexed keywords

ESTROGEN RECEPTOR ALPHA; LIGAND; PROTEIN PS2; TRANSCRIPTION FACTOR;

AMINO TERMINAL SEQUENCE; ARTICLE; CHROMATIN; COMPLEX FORMATION; CONTROLLED STUDY; CPG ISLAND; ESTROGEN RESPONSIVE ELEMENT; GENE REPRESSION; GENETIC ORGANIZATION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; METHYLATION; PRIORITY JOURNAL; PROMOTER REGION;

APOPROTEINS; BIOLOGICAL CLOCKS; BREAST NEOPLASMS; CHROMATIN; CHROMATIN IMMUNOPRECIPITATION; CPG ISLANDS; DNA METHYLATION; EPIGENESIS, GENETIC; ESTROGEN RECEPTOR ALPHA; ESTROGENS; GENE EXPRESSION REGULATION, NEOPLASTIC; GROWTH SUBSTANCES; HUMANS; LIGANDS; MEMBRANE PROTEINS; NUCLEOSOMES; PRESENILIN-2; PROMOTER REGIONS (GENETICS); PROTEIN ISOFORMS; TRANS-ACTIVATION (GENETICS); TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC;

EID: 20844451181     PISSN: 02614189     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.emboj.7600377     Document Type: Article

References (50)

1. Barkhem T, Haldosén LA, Gustafsson JA, Nilsson S (2002) Transcriptional synergism on the pS2 gene promoter between a p160 coactivator and ERα depends on the coactivator subtype, the type of ERE, and the promoter context. Mol Endocrinol 16: 2571-2581
2. Bauer UM, Daujat S, Nielsen SJ, Nightingale K, Kouzarides T (2002) Methylation at arginine 17 of histone H3 is linked to gene activation. EMBO Rep 31: 39-44
3. Belandia B, Parker MG (2003) Nuclear receptors: a rendezvous for chromatin remodeling factors. Cell 114: 277-280
4. Bian Z, Nilsson S, Gustafsson JA (2001) Selective estrogen receptor modulators and coronary heart disease. Trends Cardiovasc Med 11: 196-202
5. Bird A (2002) DNA methylation patterns and epigenetic memory. Genes Dev 16: 6-21
6. Brzozowski AM, Pike ACW, Dauter Z, Hubbard RE, Bonn T, Engström O, hman L, Greene GL, Gustafson JÅ, Carlquist M (1997) Molecular basis of agonism and antagonism in the oestrogen receptor. Nature 389: 753-757
7. Caretti G, Salsi V, Vecchi C, Imbriano C, Mantovani R (2003) Dynamic recruitment of NF-Y and histone acetyltransferases on cell-cycle promoters. J Biol Chem 278: 20435-30440
8. Denger S, Reid G, Koš M, Flouriot G, Parsch D, Brand H, Korach KS, Sonntag-Buck V, Gannon F (2001) ERα gene expression in human primary osteoblasts evidence for the expression of two receptor proteins. Mol Endocrinol 15: 2064-2077
9. Downes M, Ordentlich P, Kao HY, Alvarez JG, Evans RM (2000) Identification of a nuclear domain with deacetylase activity. Proc Natl Acad Sci USA 97: 10330-10335
10. Fawell SE, White R, Hoare S, Sydenham M, Page M, Parker MG (1990) Inhibition of estrogen receptor-DNA binding by the 'pure' antiestrogen ICI 164,384 appears to be mediated by impaired receptor dimerization. Proc Natl Acad Sci USA 87: 6883-6887
11. Faye JC, Fargin A, Bayard F (1986) Dissimilarities between the uterine estrogen receptor in cytosol of castrated and estradiol-treated rats. Endocrinology 118: 2276-2283
12. Flouriot G, Brand H, Denger S, Métivier R, Koš M, Reid G, Sonntag-Buck V, Gannon F (2000) Identification of a new isoform of the human estrogen receptor-α (hER-α) that is encoded by distinct transcripts and that is able to repress hER-α activation function. EMBO J 19: 4688-4700
13. Gaston K, Jayaraman PS (2003) Transcriptional repression in eukaryotes: repressors and repression mechanisms. Cell Mol Life Sci 60: 721-741
14. Guenther MG, Barak O, Lazar MA (2001) The SMRT and N-CoR corepressors are activating cofactors for histone deacetylase 3. Mol Cell Biol 21: 6091-6101
15. Guermah M, Tao Y, Roeder RG (2001) Positive and negative TAF(II) functions that suggest a dynamic TFIID structure and elicit synergy with traps in activator-induced transcription. Mol Cell Biol 21: 6882-6894
16. Hatzis P, Talianidis I (2002) Dynamics of enhancer-promoter communication during differentiation-induced gene activation. Mol Cell 10: 1467-1477
17. Heinzel T, Lavinsky RM, Mullen TM, Soderstrom M, Laherty CD, Torchia J, Yang WM, Brard G, Ngo SD, Davie JR, Seto E, Eisenman RN, Rose DW, Glass CK, Rosenfeld MG (1997) A complex containing N-CoR, mSin3 and histone deacetylase mediates transcriptional repression. Nature 387: 43-48
18. Honjo H, Iwasa K, Fushiki S, Hosoda T, Tatsumi H, Mihara M, Hirasugi Y, Oida M, Kariya K, Kikuchi N, Kawata M (2003) Estrogen and non-feminizing estrogen for Alzheimer's disease. Endocr J 50: 361-367
19. Jepsen K, Rosenfeld MG (2002) Biological roles and mechanistic actions of co-repressor complexes. J Cell Sci 115: 689-698
20. Jordan VC, Gapstur S, Morrow M (2001) Selective estrogen receptor modulation and reduction in risk of breast cancer, osteoporosis, and coronary heart disease. J Natl Cancer Inst 93: 1449-1457
21. Jozan S, Julia AM, Carretie A, Eche N, Maisongrosse V, Fouet B, Marques B, David JF (1991) 65 and 47kDa forms of estrogen receptor in human breast cancer: relation with estrogen responsiveness. Breast Cancer Res Treat 19: 103-109
22. Rang YK, Guermah M, Yuan CX, Roeder RG (2002) The TRAP/Mediator coactivator complex interacts directly with estrogen receptors α and β through the TRAP220 subunit and directly-enhances estrogen receptor function, in vitro. Proc Natl Acad Sci USA 99: 2642-2647
23. Kao HY, Downes M, Ordentlich P, Evans, RM; (2000) Isolation of a novel histone deacetylase reveals that class I and class II deacetylases promote SMRT-mediated repression. Genes Dev 14: 55-66
24. Katan-Khaykovich Y, Struhl K (2002) Dynamis of global histone acetylation and deacetylation in vivo; rapid restoration of normal histone acetylation status upon removal of activators and repressors. Genes Dev 16: 743-752
25. Koš M, Denger S, Reid G, Korach KS, Gannon F (2002) Down but not out? A novel protein isoform of the estrogen receptor alpha is expressed in the estrogen receptor alpha knockout mouse. J Mol Endocrinol 29: 281-286
26. Krust A, Green S, Argos P, Kumar V, Walter P, Bornert JM, Chambon P (1986) The chicken oestrogen receptor sequence: homology with v-erbA and the human oestrogen and glucocorticoid receptors. EMBO J 5: 891-897
27. Li L, Haynes MP, Bender JR (2003) Plasma membrane localization and function of the estrogen receptor alpha variant (ER46) in human endothelial cells. Proc Natl Acad Sci USA 100: 4807-4812
28. Liu XF, Bagchi MK (2004) Recruitment of distinct chromatin modifying complexes by tamoxifen-complexed estrogen receptor at natural target gene promoters in vivo. J Biol Chem 279: 15050-15058
29. Malik S, Guermah M, Roeder RG (1998) A dynamic model for PC4 coactivator function in RNA polymerase II transcription. Proc Natl Acad Sci USA 95: 2192-2197
30. McDougall KE, Perry MJ, Gibson RL, Colley SM, Korach KS, Tobias JH (2003) Estrogen receptor-α dependency of estrogen's stimulatory action on cancellous bone formation in male mice. Endocrinology 144: 1994-1999
31. Mérot Y, Métivier R, Penot G, Manu D, Saligaut C, Gannon F, Pakdel F, Kah O, Flouriot G (2004) The relative contribution exerted by AF-1 and AF-2 transactivation functions in ERα transcriptional activity depends upon the differentiation stage of the cell. J Biol Chem 279: 26184-26191
32. Métivier R, Penot G, Hubner MR, Reid G, Brand H, Koš M, Gannon F (2003) ERα directs ordered, cyclical, and combinatorial recruitment of cofactors on a natural target promoter. Cell 115: 751-763
33. Métivier R, Stark A, Flouriot G, Hubner MR, Brand H, Penot G, Manu D, Denger S, Reid G, Koš M, Russell RB, Kah O, Pakdel F, Gannon F (2002) A dynamic structural model for ERα activation by ligands, emphasizing the role of interactions between distant A and E domains. Mol Cell 10: 1019-1032
34. Nelson JE, Krawetz SA (1992) Purification of cloned and genomic DNA by guanidine thiocyanate/isobutyl alcohol fractionation. Anal Biochem 207: 197-201
35. Nilsson S, Makela S, Treuter E, Tujague M, Thomsen J, Andersson G, Enmark E, Pettersson K, Warner M, Gustafsson JA (2001) Mechanisms of estrogen action. Physiol Rev 81: 1535-1565
36. NR Committee (1999) A unified nomenclature system for the nuclear receptor superfamily. Cell 97: 161-163
37. Nye AC, Rajendran RR, Stenoien DL, Mancini MA, Katzenellenbogen BS, Belmont AS (2002) Alteration of large-scale chromatin structure by estrogen receptor. Mol Cell Biol 22: 3437-3449
38. Pendaries C, Darblade B, Rochaix P, Krust A, Chambon P, Korach KS, Bayard F, Arnal JF (2002) The AF-1 activation-function of ERα may be dispensable to mediate the effect of estradiol on endothelial NO production in mice. Proc Natl Acad Sci USA 99: 2205-2210
39. Reid G, Hubner MR, Métivier R, Brand H, Denger S, Manu D, Beaudouin J, Ellenberg J, Gannon F (2003) Cyclic, proteasome-mediated turnover of unliganded and liganded ERalpha on responsive promoters is an integral feature of estrogen signaling. Mol Cell 11: 695-707
40. Robinson-Rechavi M, Garcia EG, Laudet V (2003) The nuclear receptor superfamily. J Cell Sci 116: 585-586
41. Robyr D, Wolffe AP, Wahli W (2000) Nuclear hormone receptor coregulators in action: diversity for shared tasks. Mol Endocrinol 14: 329-347
42. Sewack GF, Hansen U (1997) Nucleosome positioning and transcription-associated chromatin alterations on the human estrogen-responsive pS2 promoter. J Biol Chem 272: 31118-31129
43. Shang Y, Hu X, DiRenzo J, Lazar MA, Brown M (2000) Cofactor dynamics and sufficiency in estrogen receptor-regulated transcription. Cell 103: 843-852
44. Shao D, Lazar MA (1999) Modulating nuclear receptor function: may the phos be with you. J Clin Invest 103: 1617-1618
45. Sterner DE, Berger SL (2000) Acetylation of histones and transcription-related factors. Microbiol Mol Biol Rev 64: 435-459
46. Urnov FD (2003) Chromatin as a tool for the study of genome function in cancer. Ann NY Acad Sci 983: 5-21
47. Wang H, Huang ZQ, Xia L, Feng Q, Erdjument-Bromage H, Strahl BD, Briggs SD, Allis CD, Wong J, Tempst P, Zhang Y (2001) Methylation of histone H4 at arginine 3 facilitating transcriptional activation by nuclear hormone receptor. Science 293: 853-857
48. Watanabe M, Yanagisawa J, Kitagawa H, Takeyama K, Ogawa S, Arao Y, Suzawa M, Kobayashi Y, Yano T, Yoshikawa H, Masuhiro Y, Kato S (2001) A subfamily of RNA-binding DEAD-box proteins acts as an estrogen receptor alpha coactivator through the N-terminal activation domain (AF-1) with an RNA coactivator, SRA. EMBO J 20: 1341-1352
49. Zegerman P, Canas B, Pappin D, Kouzarides T (2002) Histone H3 lysine 4 methylation disrupts binding of nucleosome remodeling and deacetylase (NuRD) represser complex. J Biol Chem 277: 11621-11624
50. Zhang Y, Ng HH, Erdjument-Bromage H, Tempst P, Bird A, Reinberg D (1999) Analysis of the NuRD subunits reveals a histone deacetylase core complex and a connection with DNA methylation. Genes Dev 13: 1924-1935